Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
复制标题
抗磷脂抗体介导的膜联蛋白-V 抗血栓盾的破坏:抗磷脂综合征的血栓形成机制。
DOI:
10.1006/jaut.2000.0410
复制
发表时间:
2000
期刊:
影响因子:
--
通讯作者:
Rand,JH
中科院分区:
文献类型:
--
作者:
Rand,JH
The mechanism(s) for thrombosis and pregnancy losses in the anti-phospholipid antibody syndrome have not yet been established. Annexin-V is an anionic phospholipid-binding protein with potent anticoagulant activity. The protein has been shown to be necessary for the maintenance of placental integrity and may play a thromboregulatory role at the maternal–fetal interface. There, it assembles over the apical surfaces of the placental villi and shields the underlying anionic phospholipids from availability for complexation with coagulation proteins. We have proposed that thrombosis and pregnancy loss in the antiphospholipid syndrome may be due to the disruption of the annexin-V shield by antiphospholipid (and co-factor) antibodies. The data accumulated from tissue immunohistochemistry, trophoblast and endothelial cell culture studies, coagulation studies using non-cellular phospholipids, and competition studies on artificial phospholipid bilayer are consistent with this hypothesis.
登录
查看更多内容
影响因子:
4
作者:
Niemeyer,CM;Hitchcock-Bryan,S;Sallan,SE
通讯作者:
Sallan,SE
影响因子:
5.2
作者:
A. Oakhill;D. Mainwaring;F. Hill;P. Gornall;R. Cudmore;A. Banks;J. Brock;J. Martin;J. Mann
通讯作者:
J. Mann
DOI:
--
发表时间:
1984
期刊:
Medical and Pediatric Oncology
影响因子:
--
作者:
J. Ortega;G. Javier;N. Torán
通讯作者:
N. Torán
DOI:
10.1200/jco.1984.2.8.924
发表时间:
1984
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Bowman,WP;Aur,RJ;Hustu,HO;Rivera,G
通讯作者:
Rivera,G
影响因子:
3.3
作者:
K. Y. Wong;E. Ballard;F. Strayer;C. Kisker;B. Lampkin
通讯作者:
B. Lampkin